Author:
Meier Adam,Yopp Adam,Mok Huram,Kandunoori Pragathi,Tiro Jasmin,Singal Amit G.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference29 articles.
1. El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142(1264–1273), e1261.
2. El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Annals of Internal Medicine, 139, 817–823.
3. Bruix, J., & Sherman, M. (2010). Management of hepatocellular carcinoma: An update. Hepatology, 53, 1–35.
4. Altekruse, S. F., McGlynn, K. A., Dickie, L. A., & Kleiner, D. E. (2012). Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology, 55, 476–482.
5. Tan, D., Yopp, A., Beg, M. S., Gopal, P., & Singal, A. G. (2013). Meta-analysis: Underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States. Alimentary Pharmacology & Therapeutics, 38, 703–712.